Tommy Thompson joins United Therapeutics' board
This article was originally published in Scrip
United Therapeutics (US) has appointed the Honorable Tommy Thompson, former secretary of the US Department of Health and Human Services and governor of Wisconsin, to its board as an independent director, effective January 1st.
You may also be interested in...
Tactic aims to allow incoming Administration to scrutinize so-called ‘midnight rules’ issued in the final days of the Trump Administration before they take effect. Regulators may also solicit stakeholder comments on delayed rules.
Pharmaceutical manufacturers should have already begun serializing products and verifying saleable returns to comply with DSCSA, says FDA official who also asserted that licensing standards for wholesale distributors and third-party logistics providers will be forthcoming. This rule is already six years overdue under a DSCSA mandated timeline.
On a “strong first half of the base,” P&G increased FY2021 guidance for organic sales growth and core earnings per share despite a “sequential deceleration” in US consumption in its categories in December and so far in January.